Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Rev Med Interne ; 39(3): 161-170, 2018 Mar.
Article in French | MEDLINE | ID: mdl-28457684

ABSTRACT

Two categories of renal disorders associated with monoclonal gammopathies are to be distinguished, according to the characteristics of the underlying B-cell clone. The first group of renal diseases always occurs in the setting of high tumor mass with production of large amounts of monoclonal immunoglobulins. The main complication is the so-called myeloma cast nephropathy, which almost invariably complicates high tumor mass myeloma. The second group includes all renal disorders caused by a monoclonal immunoglobulin secreted by a nonmalignant B-cell clone, and currently referred as a "monoclonal gammopathy of renal significance (MGRS)". This term was introduced to distinguish monoclonal gammopathies that are responsible for the development of kidney damage from those that are truly benign. The spectrum of renal diseases in MGRS is wide and its classification relies on the localization of renal lesions, either glomerular or tubular, and on the pattern of ultrastructural organization of immunoglobulin deposits. Physicochemical characteristics of the pathogenic monoclonal immunoglobulin are probably involved in their propensity to deposit or precipitate in the kidney, as illustrated by the high rate of recurrence of each specific type after kidney transplantation. Early diagnosis and efficient chemotherapy targeting the causal B-cell clone are mandatory to improve renal prognosis and patient survival.


Subject(s)
Kidney Diseases/etiology , Kidney Diseases/therapy , Paraproteinemias/classification , Paraproteinemias/complications , Paraproteinemias/therapy , Amyloidosis/complications , Amyloidosis/epidemiology , Amyloidosis/pathology , Amyloidosis/therapy , Diagnostic Techniques and Procedures , Humans , Kidney/pathology , Kidney Diseases/classification
3.
Proc Natl Acad Sci U S A ; 103(20): 7747-52, 2006 May 16.
Article in English | MEDLINE | ID: mdl-16682638

ABSTRACT

Mice in which the Jkappa cluster was replaced with a VkappaJkappa rearranged gene were studied. More than 90% of B cells from homozygous mutant mice expressed the transgenic kappa chain but showed a slightly reduced level of kappa transcripts compared with WT B lymphocytes. Light chain inclusion was apparent in 10% of B cells from these mice and raised 25% in hemizygous mice with a still lower expression of the knockin kappa chain. Beyond the rules of clonal selection, peripheral B cells developed in such animals, with included cells being activated and differentiating into class-switched or antibody-secreting cells. The high amount of included mature B cells was associated with an increase of hybrid kappa/lambda immunoglobulins but not with the increased prevalence of autoantibodies. Altogether, these data suggest that light chain exclusion prevalent in normal B cells mostly results from ordered rearrangements and stochastic mechanisms but is neither tightly ensured by a stringent cell selection process nor absolutely required for normal B cell function.


Subject(s)
B-Lymphocytes , Cell Differentiation/physiology , Gene Rearrangement, B-Lymphocyte, Light Chain , Immunoglobulin Light Chains , Animals , Autoantibodies/metabolism , B-Lymphocytes/immunology , B-Lymphocytes/physiology , Cell Lineage , Humans , Hybridomas/immunology , Immunoglobulin kappa-Chains/genetics , Immunoglobulin kappa-Chains/metabolism , Immunoglobulin lambda-Chains/genetics , Immunoglobulin lambda-Chains/metabolism , Mice , Mice, Transgenic , Multigene Family , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Spleen/cytology , Transgenes
SELECTION OF CITATIONS
SEARCH DETAIL
...